Retinopathy of prematurity

Current Paediatrics

Volumn 6, Issue 1, 1996, Pages 56-61

  Fielder, A R ^a  

^a WESTERN EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 23044453244     PISSN: 09575839     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0957-5839(96)80061-3     Document Type: Article

References (33)

1. Gibson DL, Sheps SB, Uh SH, Schechter MT, McCormick AQ. Retinopathy of prematurity-induced blindness, birth weight-specific survival and the new epidemic. Pediatrics 1990; 86: 405-412.
2. Keith CG, Doyle LW. Retinopathy of prematurity in infants weighing 1000-1499g at birth. J Paediatr Child Health 1995; 31: 134-136.
3. Darlow BA, Horwood LJ, Clemett RS. Retinopathy of prematurity: risk factors in a prospective population-based study. Paed and Perinat Epidem 1992; 6: 62-80.
4. Schaffer DB et al, on behalf of the Cryotherapy for Retinopathy of Prematurity Cooperative Group. Prognostic factors in the natural course of retinopathy of prematurity. Ophthalmology 1993; 100: 230-237.
5. Gilbert CF, Canovas R, Kocksch de Canovas R, Foster A. Causes of blindness and severe visual impairment in children in Chile. Dev Med Child Neurol 1994; 36: 326-333.
6. Saigal S, Rosenbaum P, Hattersley B, Milner R. Decreased survival among 3-year-old survivors weighing 501 to 1000 grams at birth and born to residents of a geographically defined region from 1981 to 1984 compared with 1977 to 1980. J Pediatr 1989; 114: 839-846.
7. Lucey JL, Dangman B. A re-examination of the role of oxygen in retrolental fibroplasia. Pediatrics 1984; 73: 82-96.
8. Prendiville A, Schulenburg WE. Clinical factors associated with retinopathy of prematurity. Arch Dis Child 1988; 63: 522-527.
9. Gallo JE, Jacobson L, Broberger. Perinatal factors associated with retinopathy of prematurity. Acta Paediatr 1993; 82: 829-834.
10. Repka MX, Hardy RJ, Phelps DL, Summers G. Surfactant prophylaxis and retinopathy of prematurity. Arch Ophthalmol 1993; 111: 618-620.
11. Weakley DR, Spencer R. Current concepts in retinopathy of prematurity. Early Hum Dev 1992; 30: 121-138.
12. Teoh SL, Boo NY, Ong LC, Nyein MK, Lye MS, Au MK. Duration of oxygen therapy and exchange transfusion as risk factors associated with retinopathy of prematurity in very low birthweight infants. Eye 1995; 9: 733-737.
13. Flynn JT, Bancalari E, Snyder ES, Goldberg RN, Feuer W, Cassady J et al. A cohort study of transcutaneous oxygen monitoring and the incidence and severity of retinopathy of prematurity. N Engl J Med 1992; 326: 1050-1054.
14. Cunningham S, Fleck BW, Elton RA, McIntosh N. Transcutaneous oxygen levels in retinopathy of prematurity. Lancet 1995; 346: 1464-1465.
15. Saito Y, Omoto T, Cho Y, Hatsukawa Y, Fujimua M, Takeuchi T. The progression of retinopathy of prematurity and fluctuation in blood gas tension. Graefe's Arch Clin Exp Ophthalmol 1993; 231: 151-156.
16. Fielder AR, Robinson J, Shaw DE, Ng YK, Moseley MJ. Light and retinopathy of prematurity does retinal location offer a clue? Pediatrics 1992; 89: 648-653.
17. Glass P, Avery GB, Kolinjavadi N, et al. Effect of bright light in the hospital nursery on the incidence of retinopathy of prematurity. N Engl J Med 1985; 313: 401-404.
18. Seiberth V, Linderkamp O, Knorz MC, Liesenhoff H. A controlled trial of light and retinopathy of prematurity. Am J Ophthalmol 1994; 118: 492-495.
19. Committee for the Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity. Br J Ophthalmol 1984; 68: 690-697.
20. Fielder AR, Levene MI. Screening for retinopathy of prematurity. Arch Dis Child 1992; 67: 860-867.
21. Report of a Joint Working Party. Retinopathy of Prematurity: Guidelines for Screening and Treatment. Royal College of Ophthalmologists and British Association of Perinatal Medicine, 1995.
22. Fielder AR, Shaw DE, Robinson J, Ng YK. Natural history of retinopathy of prematurity: a prospective study. Eye 1992; 6: 233-242.
23. Palmer EA et al, The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Incidence and early course of retinopathy of prematurity. Ophthalmology 1991; 98: 1628-1640.
24. Ashton N. Oxygen and retinal blood vessels. Trans Ophthalmol Soc UK 1980; 100: 359-362.
25. Patz A. Retrolental fibroplasia (retinopathy of prematurity) Trans Ophthalmol Soc NZ 1980; 32: 49-54.
26. Kretzer FL, Hittner HM. Retinopathy of prematurity: clinical implications of retinal development. Arch Dis Child 1988; 63: 1151-1167.
27. Alon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nature Med 1995; 1: 1024-1028.
28. Hungerford J, Stewart A, Hope P. Ocular sequelae of preterm birth and their relation to ultrasound evidence of cerebral damage. Br J Ophthalmol 1986; 70: 463-468.
29. Ng YK, Fielder AR. Levene MI, Trounce JQ, McLellan N. Are severe retinopathy of prematurity and severe periventricular leukomalacia both ischaemic insults? Br J Ophthalmol 1989; 73: 111-114.
30. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: preliminary results. Arch Ophthalmol 1988; 106. 471-479.
31. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity. 31/2 year outcome - structure and function. Arch Ophthalmol 1993; 111: 339-344.
32. McNamara JA. Laser treatment for retinopathy of prematurity. Current Opinion Ophthalmol 1993, 4: 111: 76-80.
33. Javitt J, Cas RD, Chiang Y-P. Cost-effectiveness of screening and cryotherapy for threshold retinopathy of prematurity. Pediatrics 1993; 91: 859-866.